Cracking Down on Vaccinations

A handful of US states are enacting laws that make it harder for parents to opt out of vaccinating their children against infectious diseases.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Image: United States Department of Health and Human ServicesState legislatures across the US are trying to increase the number of children who receive vaccinations against disease by enacting laws that make opting out of those shots tougher for parents. California, Vermont, and Washington—states that allow parents to decline scheduled vaccinations for their children for personal or philosophical reasons—require parents opting out to provide proof that a health-care practitioner or representative of the state's health department gave them scientific information about the risks and benefits of those vaccinations. State lawmakers in New Jersey and Arizona have floated ideas for similar legislation.

Even in the face of recent outbreaks of whooping cough and other diseases, vaccine exemption rates are rising across the nation. An average of 1.5 percent of US children entering kindergarten in 2010-2011 had an exemption, and rates in some states are even higher. "There really is a problem when you don't have herd immunity so that you can stop the infectious diseases," Washington Senator Karen Keiser (D) told Nature. The problem risks becoming worse in states, such as Kansas, Mississippi, Massachusetts, South Dakota, and West Virginia, that have recently tried to enact laws that permit philosophical exemptions. But states that have strengthened exemption requirements are already seeing positive results. Washington, for example, has seen kindergarten exemption rates drop to 4.5 percent this year from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo